Effect of led photobiomodulation on tooth movement, gingival hypertrophy and pain in response to treatment with fixed orthodontic appliance
Lasers in Medical Science · 2025
DOI: 10.1007/s10103-025-04444-5 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Lasers in Medical Science, 2025. Verfasst von Anja Sedej und 7 weiteren Autor:innen. Beteiligte Einrichtung: Orthos Institute, Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Tooth Movement Techniques, Low-Level Light Therapy, Orthodontic Appliances, Fixed, Gingival Hypertrophy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Javna Agencija za Raziskovalno Dejavnost RS.
Abstract (Originalsprache)
Photobiomodulation (PBM) is a form of treatment that uses low-power red and near-infrared light to stimulate tissue repair and regeneration at the cellular level. 32 subjects (198 teeth examined), 10 males and 22 females aged 14.6 ± 2.0 years, with mild dental crowding were included in a randomised, controlled clinical trial. The patients were treated with a fixed orthodontic appliance (FOA). Subjects were randomised into an experimental group (a PBM group irradiated with an LED light source with wavelengths of 625 nm, 660 nm and 850 nm simultaneously and an irradiance of 16 mW/cm²) and a placebo control group that received non-therapeutic irradiation with visible light. PBM therapy began within the first 2 days of appliance insertion and was administered twice weekly for 4 weeks. The rate of tooth movement (a change in distance at the same selected point on the occlusal plane of the tooth determined by measurements on 3D models), the presence of gingival hypertrophy (with a free gingival margin of at least 1 mm occlusal to the enamel-cement junction), the plaque index (PI), the sulcus bleeding index (SBI) and the subjective pain sensation using the visual analogue scale (VAS) were monitored. In the experimental PBM group ( N = 14), the rate of movement with the FOA was statistically significantly higher at both 1 week of placement (0.5 mm [95%CI: 0.4–0.8]) and 4 weeks (1.1 mm [95%CI: 0.8–1.4]) than in the placebo group ( N = 18), where the values were (0.4 mm [95%CI: 0.2–0.5]) at 1 week and (0.6 mm [95%CI: 0.4–0.9]) at 4 weeks. A lower incidence of gingival hypertrophy was observed in the PBM group (21.4%) than in the placebo group (55.6%) after 4 weeks (Mann-Whitney U-test, p < 0.05). PBM with LED accelerated orthodontic tooth movement during the levelling and alignment phase and reduced the incidence of gingival hypertrophy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Orthos Institute, Ljubljana, Slovenia.
- Public Health Center Radovljica, Radovljica, Slovenia.
- University of Ljubljana, Ljubljana, Slovenia. aljaz.golez@mf.uni-lj.si.
- University of Ljubljana, Ljubljana, Slovenia.
- Ljubljana University Medical Centre, Ljubljana, Slovenia.
Förderung
- Javna Agencija za Raziskovalno Dejavnost RS
Zitieren
APA
Sedej, A., Svetina, N., Golez, A., Cankar, K., Ban Frangez, H., Frangez, I., Ovsenik, M., & Nemeth, L. (2025). Effect of led photobiomodulation on tooth movement, gingival hypertrophy and pain in response to treatment with fixed orthodontic appliance. Lasers in Medical Science. https://doi.org/10.1007/s10103-025-04444-5
Vancouver
Sedej A, Svetina N, Golez A, Cankar K, Ban Frangez H, Frangez I, et al. Effect of led photobiomodulation on tooth movement, gingival hypertrophy and pain in response to treatment with fixed orthodontic appliance. Lasers in Medical Science. 2025. doi:10.1007/s10103-025-04444-5
BibTeX
@article{Sedej2025,
author = {Sedej, Anja and Svetina, Nika and Golez, Aljaz and Cankar, Ksenija and Ban Frangez, Helena and Frangez, Igor and Ovsenik, Maja and Nemeth, Lidija},
title = {Effect of led photobiomodulation on tooth movement, gingival hypertrophy and pain in response to treatment with fixed orthodontic appliance},
journal = {Lasers in Medical Science},
year = {2025},
doi = {10.1007/s10103-025-04444-5}
}
EUVIMED